The Trap Hep C programme in Iceland is a pioneering project established in 2016 as a collaborative initiative between the Icelandic Ministry of Health and Gilead with one simple aim: to achieve the elimination of hepatitis C in Iceland as a major health threat – for the benefit of Icelanders and to provide a model to enable other countries and regions to follow their lead.3-5

At the start of the project in 2016 it was estimated that there were 800 people living with the virus on the island (diagnosed and undiagnosed) with a large proportion of HCV sufferers being those at high risk of transmission, including PWID 6-8Three years later, around 80% of those living with HCV in Iceland have been cured.6  

As a result of the TraP Hep C programme, elimination of hepatitis C as a major health threat in Iceland looks possible.9

Watch the full Trap Hep C programme case study

 

For further information, contact:

Ragnheiður Hulda Friðriksdóttir, B.Sc, MBA

Project Manager
Landspítali, Hringbraut, 101 Reykjavík

Tel: 543 6096

Mobile: 824 5829

Further presentations and publications on hepatitis C in Iceland and the Trap Hep C programme:

  • Olafsson, S et al. Iceland may already have reached the WHO 2030 targets for diagnosis and treatment of hepatitis C virus infection. Results from the Treatment as Prevention for Hepatitis C (TrapHepC) program. Available at http://www.natap.org/2019/EASL/EASL_116.htm.
  • Olafsson S, et al. Treatment as Prevention for Hepatitis C (TraP Hep C) – a nationwide elimination programme in Iceland using direct-acting antiviral agents. J Intern Med 2018;283:500–507.
  • Rockstroh J. Summary from EASL 2018 for Hepatitis C (HCV). HCV in 2018: Success stories and remaining challenges? Available at: http://www.natap.org/2018/EASL/EASL_93.htm.
  • Gottfredsson M. Preliminary results from the Treatment as Prevention for Hepatitis C (TraP HepC) program in Iceland. Presented at the HIV and Hepatitis Nordic Conference 2018, Stockholm, Sweden.
  • Olafsson S. Implementation of a successful treatment program for hepatitis C presented at the HIV and Hepatitis Nordic Conference 2018, Stockholm, Sweden.
  • Olafsson S. Trap HepC (Treatment as prevention for hepatitis C in Iceland): An update. Poster presented at Stockholm Liver Week 2017, Stockholm, Sweden.
  • Love A and Stanzeti B. Hepatitis C virus infection in Iceland: a recently introduced bloodborne disease. Epidemiol Infect 1994;113:529–536.

References

  1. World Health Organization (WHO). Global health sector strategy on viral hepatitis 2016–2021.June 2016. Available at: http://apps.who.int/iris/bitstream/handle/10665/246177/WHO-HIV-2016.06-eng.pdf?sequence=1 (accessed February 2019).
  2. World Hepatitis Day. Find the Missing Millions. 2019. Available at  http://www.worldhepatitisday.org/ Last accessed July 2019
  3. Olafsson S, et al. Treatment as Prevention for Hepatitis C (TraP Hep C) – a nationwide elimination programme in Iceland using direct-acting antiviral agents. J Intern Med 2018;283:500–507.
  4. Olafsson S. Trap Hep C (Treatment as prevention for hepatitis C in Iceland): An update. Poster presented at Stockholm Liver Week 2017, Stockholm, Sweden.
  5. Olafsson S. Implementation of a successful treatment program for hepatitis C presented at the HIV and Hepatitis Nordic Conference 2018, Stockholm, Sweden.
  6. Rockstroh J. Summary from EASL 2018 for Hepatitis C (HCV). HCV in 2018: Success stories and remaining challenges? Available at: http://www.natap.org/2018/EASL/EASL_93.htm (accessed July 2019).
  7. Love A and Stanzeti B. Hepatitis C virus infection in Iceland: a recently introduced bloodborne disease. Epidemiol Infect 1994;113:529–536.
  8. Gottfredsson M. Preliminary results from the Treatment as Prevention for Hepatitis C (TraP HepC) program in Iceland. Presented at the HIV and Hepatitis Nordic Conference 2018, Stockholm, Sweden
  9. Olafson, S et al. Iceland may already have reached the WHO 2030 targets for diagnosis and treatment of hepatitis C virus infection. Results from the Treatment as Prevention for Hepatitis C (TrapHepC) program. Available at http://www.natap.org/2019/EASL/EASL_116.htm

 

HCV/IHQ/19-09//2099 • Date of Preparation: September 2019